GMED (Globus Medical) Ending Cash Position: $508 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GMED Globus Medical Inc GMED
95 GF Score
Price $74.29
GF Value $97.01
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Globus Medical Ending Cash Position?

Globus Medical GMED +0.28% 95 Ending Cash Position is $508 Mil as of Jun. 2026. GuruFocus rates GMED with a GF Score™ of 95/100 and a GF Value™ of $97.01 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Globus Medical's Ending Cash Position for the quarter that ended in Jun. 2026 was $508 Mil.

Globus Medical's quarterly Ending Cash Position increased from Dec. 2025 ($526 Mil) to Mar. 2026 ($561 Mil) but then declined from Mar. 2026 ($561 Mil) to Jun. 2026 ($508 Mil).

Globus Medical's annual Ending Cash Position increased from Dec. 2023 ($467 Mil) to Dec. 2024 ($784 Mil) but then declined from Dec. 2024 ($784 Mil) to Dec. 2025 ($526 Mil).

Globus Medical Ending Cash Position Related Terms

Globus Medical Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Globus Medical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical Ending Cash Position Chart

Globus Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 193.07 150.47 467.29 784.44 526.16

Globus Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 229.45 371.77 526.16 560.95 507.75
GMED
95GF Score
Globus Medical Inc GMED
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Globus Medical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Globus Medical's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=784.438+-258.282
=526

Globus Medical's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=560.95+-53.205
=508

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $508 Mil mean?
Globus Medical (GMED) has a Ending Cash Position of $508 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Globus Medical and its competitors.
Is Globus Medical's Ending Cash Position too high?
Globus Medical's current Ending Cash Position is $508 Mil. Overall, Globus Medical has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Ending Cash Position compare to GKOS and BIO?
Globus Medical's Ending Cash Position of $508 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Globus Medical and its competitors. Globus Medical's current Ending Cash Position is $508 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is $97.01, compared to a current price of $74.29 — trading 23.4% below its estimated fair value. The current Ending Cash Position is $508 Mil. Globus Medical's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Globus Medical (GMED), the current Ending Cash Position is $508 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globus Medical (GMED) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of $74.29 is trading 23.4% below its estimated GF Value™ of $97.01. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for GMED:

  • Ending Cash Position: $508 Mil
  • GF Value™: $97.01 vs. price of $74.29 (23.4% below fair value)
  • GF Score™: 95/100 with 4 warning signs

No single metric tells the full story. See the GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Globus Medical Business Description

Other Exchanges GMED:MexicoGM0N:Germany
Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
95GF Score

Get the complete analysis for GMED

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$74.29
Price
$97.01
GF Value